Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
The AACR is a founder and organizing partner of the Rally for Medical Research, which took place for the...
This month is Breast Cancer Awareness Month, a type of cancer against which we have made much progress. However,...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Earlier this week, the U.S. Food and Drug Association (FDA) announced it had approved the immunotherapeutic atezolizumab (Tecentriq) for...
Cancer Today Senior Editor Marci A. Landsmann shares her experience reporting on a young lung cancer survivor, Emily Bennett...
Liver cancer rates have been on the rise in the United States and have tripled in the last four...
Understanding the identity of the factors that increase risk for a particular type of cancer is vital for developing...
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
In examination rooms all around the country, a big decision turns on a single moment. A pediatrician tells a...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Slightly more than 57 million people were 60...